Rationale for the design of combination therapies that are active in T-cell lymphomas?

Experimental Therapeutics

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	83-86
Number of pages	4
Journal	Haematologica Reports
Volume	2
Issue number	13
State	Published - 2006

ASJC Scopus subject areas

Hematology

Other files and links

Cite this

@article{9822e25d9fd74ad29c764f5215eaf7d3,

title = "Rationale for the design of combination therapies that are active in T-cell lymphomas?",

author = "W. Plunkett",

year = "2006",

language = "English (US)",

volume = "2",

pages = "83--86",

journal = "Haematologica Reports",

issn = "1824-9337",

publisher = "Fondazione Ferrata Storti Onlus",

number = "13",

}

TY - JOUR

T1 - Rationale for the design of combination therapies that are active in T-cell lymphomas?

AU - Plunkett, W.

PY - 2006

Y1 - 2006

UR - http://www.scopus.com/inward/record.url?scp=46849114744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46849114744&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:46849114744

SN - 1824-9337

VL - 2

SP - 83

EP - 86

JO - Haematologica Reports

JF - Haematologica Reports

IS - 13

ER -